Skip to main content
. 2024 Dec 30;9:100251. doi: 10.1016/j.bioflm.2024.100251

Table 1.

Summary of quality control of RNA-seq results generated in the study.

Group Sample name Raw reads (bp) Clean reads (bp) Q20 (%) Q30 (%) GC (%) Mapped read Mapping ratio (%)
Control C-90028-1 45,097,848 44,323,338 98.99 97.09 37.36 41,827,145 94.37
C-90028-2 41,389,912 40,709,300 98.95 96.99 37.36 38,409,668 94.35
C-90028-3 50,467,472 48,313,668 97.99 94.00 37.11 45,271,080 93.70
C-X27-1 40,857,914 40,122,876 98.97 97.04 37.11 37,042,163 92.32
C-X27-2 46,636,704 45,784,742 98.97 97.08 37.10 42,342,463 92.48
C-X27-3 48,267,404 46,184,228 98.11 94.40 37.48 41,671,692 90.23
EPA E−90028-1 46,980,998 45,757,454 98.71 96.48 37.41 43,440,221 94.94
E−90028-2 47,358,956 46,592,240 98.77 96.60 37.52 44,125,478 94.71
E−90028-3 46,548,132 45,796,242 98.74 96.54 36.96 43,203,889 94.34
E-X27-1 44,805,798 44,212,514 98.77 96.58 37.58 41,204,463 93.20
E-X27-2 43,859,334 43,322,624 98.75 96.52 37.45 40,301,513 93.03
E-X27-3 42,673,636 42,126,644 98.75 96.53 37.24 38,907,463 92.36